cas 1089695-61-3|| where to buy 2-(difluoromethoxy)acetic acid

Nom du produit:2-(difluoromethoxy)acetic acid

IUPAC Name:2-(difluoromethoxy)acetic acid

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM460686-1g	in stock	ȋşœǺ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1089695-61-3 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1089695-61-3; Formule moléculaire:C3H4F2O3; Point de fusion:-; Code SMILES:OC(=O)COC(F)F; Densité:

: Numéro de catalogue:CM460686; Poids moléculaire:126.06; Point d'ébullition:; N° Mdl:MFCD28118272; Stockage:

: Deucrictibant; Pharvaris announced positive top-line data from the CHAPTER-1 Phase 2 clinical study meeting its primary endpoint, with deucrictibant demonstrating statistically significant and clinically meaningful results of deucrictibant as an oral preventative treatment for people living with HAE. The study's primary endpoint measured the time-standardized number of investigator-confirmed HAE episodes during treatment. Participants receiving 40 mg of deucrictibant daily had an 84.5% reduction in monthly exacerbation rates compared to placebo (p=0.0008). Deucrictibant is a potent, selective, and orally available antagonist of the bradykinin B2 receptor. By inhibiting bradykinin signaling through the bradykinin B2 receptor, deucrictibant has the potential to treat the clinical signs of an HAE attack and to prevent the occurrence of attacks.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.